Veradigm (NASDAQ:MDRX) Share Price Passes Above 200 Day Moving Average - Time to Sell?

Key Points

• Veradigm Inc.'s stock price has surpassed its 200-day moving average of $4.57, trading at a high of $4.80 recently.
• Wall Street Zen has initiated coverage on Veradigm, giving it a "hold" rating with a consensus target price of $13.00.
• The company offers a range of healthcare technology solutions including electronic health records, analytics, and population health management.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $4.57 and traded as high as $4.80. Veradigm shares last traded at $4.80, with a volume of 5,241 shares traded.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen started coverage on Veradigm in a report on Tuesday, May 20th. They set a "hold" rating for the company. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $13.00.

Veradigm Stock Performance

The firm's fifty day moving average price is $4.78 and its 200-day moving average price is $4.57.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.